CFP
AMED

Curran Financial Partners’s Amedisys AMED Stock Holding History

Curran Financial Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,920
Closed -$470K – 63
2021
Q2 		$470K Buy
1,920
+680
+55% +$178K 0.26% 47
2021
Q1 		$328K Sell
1,240
-57
-4% -$16.1K 0.24% 44
2020
Q4 		$380K Buy
+1,297
New +$333K 0.33% 42

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Curran Financial Partners's AMED Position: Q3 2021 in Review

Curran Financial Partners sold out of Amedisys (AMED) in Q3 2021, closing a stake of 1,920 shares — an estimated $470K sold.

Curran Financial Partners first reported a position in AMED in Q4 2020 and held it in 3 quarters. The position peaked at $470K in Q2 2021. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Curran Financial Partners reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Curran Financial Partners sold 1,920 Amedisys shares in Q3 2021, an estimated $470K.
  • Curran Financial Partners first reported a position in Amedisys in Q4 2020 and held it in 3 quarters.
  • Curran Financial Partners's Amedisys position peaked at $470K in Q2 2021.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Curran Financial Partners's 13F filing for Q3 2021, filed 9 Nov 2021.